These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 34360910)

  • 1. Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate.
    Wang AYL
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
    Xie M; Tang S; Li K; Ding S
    Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.
    Warren L; Manos PD; Ahfeldt T; Loh YH; Li H; Lau F; Ebina W; Mandal PK; Smith ZD; Meissner A; Daley GQ; Brack AS; Collins JJ; Cowan C; Schlaeger TM; Rossi DJ
    Cell Stem Cell; 2010 Nov; 7(5):618-30. PubMed ID: 20888316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Human iPSCs by Reprogramming with the Unmodified Synthetic mRNA.
    Annand RR
    Methods Mol Biol; 2021; 2239():163-174. PubMed ID: 33226619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.
    Rony IK; Baten A; Bloomfield JA; Islam ME; Billah MM; Islam KD
    Cell Prolif; 2015 Apr; 48(2):140-56. PubMed ID: 25643745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
    Ebrahimi B
    Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming human fibroblasts to pluripotency using modified mRNA.
    Mandal PK; Rossi DJ
    Nat Protoc; 2013 Mar; 8(3):568-82. PubMed ID: 23429718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of human β-thalassemia induced pluripotent cell lines by reprogramming of bone marrow-derived mesenchymal stromal cells using modified mRNA.
    Varela I; Karagiannidou A; Oikonomakis V; Tzetis M; Tzanoudaki M; Siapati EK; Vassilopoulos G; Graphakos S; Kanavakis E; Goussetis E
    Cell Reprogram; 2014 Dec; 16(6):447-55. PubMed ID: 25354259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic cell reprogramming as a tool for neurodegenerative diseases.
    Ebrahimi A; Keske E; Mehdipour A; Ebrahimi-Kalan A; Ghorbani M
    Biomed Pharmacother; 2019 Apr; 112():108663. PubMed ID: 30970509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High throughput sequencing identifies an imprinted gene, Grb10, associated with the pluripotency state in nuclear transfer embryonic stem cells.
    Li H; Gao S; Huang H; Liu W; Huang H; Liu X; Gao Y; Le R; Kou X; Zhao Y; Kou Z; Li J; Wang H; Zhang Y; Wang H; Cai T; Sun Q; Gao S; Han Z
    Oncotarget; 2017 Jul; 8(29):47344-47355. PubMed ID: 28476045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic mRNA Reprogramming of Human Fibroblast Cells.
    Liu J; Verma PJ
    Methods Mol Biol; 2015; 1330():17-28. PubMed ID: 26621585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor-mediated reprogramming: epigenetics and therapeutic potential.
    Firas J; Liu X; Lim SM; Polo JM
    Immunol Cell Biol; 2015 Mar; 93(3):284-9. PubMed ID: 25643615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion of Reprogramming Factors Alters the Trajectory of Somatic Lineage Conversion.
    Velychko S; Kang K; Kim SM; Kwak TH; Kim KP; Park C; Hong K; Chung C; Hyun JK; MacCarthy CM; Wu G; Schöler HR; Han DW
    Cell Rep; 2019 Apr; 27(1):30-39.e4. PubMed ID: 30943410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA-Based Reprogramming Under Xeno-Free and Feeder-Free Conditions.
    Jeriha J; Kolundzic N; Khurana P; Perez-Dominguez A; Ilic D
    Methods Mol Biol; 2022; 2454():665-674. PubMed ID: 32567019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reprogramming of somatic cells. Problems and solutions].
    Schneider TA; Fishman VS; Liskovykh MA; Ponamartsev SV; Serov OL; Tomilin AN; Alenina N
    Tsitologiia; 2014; 56(12):869-80. PubMed ID: 25929128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA-Based Genetic Reprogramming.
    Warren L; Lin C
    Mol Ther; 2019 Apr; 27(4):729-734. PubMed ID: 30598301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.